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The catalytic properties of the rotenone-sensitive NADH:ubiquinone reductase (Complex I) in bovine heart submitochondrial particles
and in inside-out vesicles derived from Paracoccus denitrificans and Rhodobacter capsulatus were compared. The prokaryotic enzymes
catalyze the NADH oxidase and NADH:quinone reductase reactions with similar kinetic parameters as those for the mammalian Complex I,
except for lower apparent affinities for the substrates—nucleotides. Unidirectional competitive inhibition of NADH oxidation by ADP-
ribose, previously discovered for submitochondrial particles, was also evident for tightly coupled P. denitrificans vesicles, thus suggesting
that a second, NAD+-specific site is present in the simpler prokaryotic enzyme. The inhibitor sensitivity of the forward and reverse electron
transfer reactions was compared. In P. denitrificans and Bos taurus vesicles different sensitivities to rotenone and Triton X-100 for the
forward and reverse electron transfer reactions were found. In bovine heart preparations, both reactions showed the same sensitivity to
piericidin, and the inhibition was titrated as a straight line. In P. denitrificans, the forward and reverse reactions show different sensitivity to
piericidin and the titrations of both activities were curvilinear with apparent I50 (expressed as mole of inhibitor per mole of enzyme)
independent of the enzyme concentration. This behavior is explained by a model involving two different sites rapidly interacting with
piericidin within the hydrophobic phase.
D 2003 Elsevier B.V. All rights reserved.Keywords: NADH:ubiquinone reductase; Complex I; NDH-1; Ubiquinone; Piericidin; Tightly bound inhibitor; Respiratory chain; Bovine heart
submitochondrial particle; Paracoccus denitrificans membrane; Rhodobacter capsulatus membrane
1. Introduction 13 (Escherichia coli) [4] or 14 (Paracoccus denitrificansThe mitochondrial proton-motive NADH:ubiquinone
oxidoreductase (Complex I) or its prokaryotic homologues
(NDH-1) couple the oxidation of NADH to NAD+ in the
mitochondrial matrix (or in cytoplasm in bacteria) with the
reduction of membranous quinone acceptor and concomi-
tant vectorial translocation of protons across the mem-
brane. The mitochondrial Complex I is of enormous
complexity. It is composed of at least 45 different poly-
peptides [1,2] and bears multiple (up to 10) redox compo-
nents [3]. The bacterial operons encoding NDH-1 contain0005-2728/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbabio.2003.09.001
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E-mail address: adv@biochem.bio.msu.su (A.D. Vinogradov).[5] and Rhodobacter capsulatus [6]) genes. Their transcrip-
tion products are highly homologous to 14 ‘‘core’’ subunits
of the mammalian Complex I [7]. It is generally accepted
that these 14 subunits harboring FMN, iron–sulfur clus-
ters, and bound ubiquinone molecules form a minimal
functional unit required for the proton-motive oxidoreduc-
tion at the first coupling site of the respiratory chain.
No three dimensional atomic structure of either bovine
Complex I or bacterial NDH-1 is available at present, and
other data, obtained by multiple biochemical and biophy-
sical approaches such as studies on catalytic activity, low-
temperature EPR, the effects of specific inhibitors, and
mutagenesis, has been used to create a number of highly
speculative models and possible mechanisms for the enzyme
operation [8–13].
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the catalytic properties and the effects of specific inhibitors
for the most complex mammalian enzyme (reviewed in
Ref. [14]) whereas much less is known about the much
simpler prokaryotic NDH-1. Limited data on the catalytic
activities of bacterial enzymes, with significant variations
of particular kinetic parameters (Vmax, Km), are scattered in
the literature [15–21]. These variations are evidently due
to differences in preparative and assay conditions
employed by different groups, and only few studies were
aimed to directly compare enzymes of different origin in
parallel [22–25]. The experiments reported here were
aimed to make a comparison of the catalytic parameters
of the membrane-bound bovine (Bos taurus), P. denitrifi-
cans, and R. capsulatus enzymes under as similar assay
conditions as possible. The bacteria were chosen due to
their particularly high primary sequence similarity with the
mammalian enzyme, and sensitivity to the same set of
classical specific inhibitors. Furthermore, we believe that
only tightly coupled membranous preparations are suitable
for studies on mechanism of energy transduction catalyzed
by Complex I, and, to our knowledge, vesicles obtained
from anaerobically grown P. denitrificans cells [26] is the
only available prokaryotic preparation demonstrating high
respiratory control. Although vesicles prepared from che-
moheterotrophically grown R. capsulatus are less tightly
coupled, this specie is of great value because genetic
modifications of NDH-1 are possible in this organism
[27,28]. Here we report the results of a direct comparison
of the enzymatic activities of bovine heart Complex I and
its prokaryotic counterparts. Although the major features of
the mitochondrial and prokaryotic enzyme are similar,
significant differences between two were found in their
mode of interaction with quinone-junction site-directed
specific inhibitors.2. Materials and methods
Bovine heart submitochondrial particles were prepared
[29] and their NADH oxidase was activated [30] as
described.
Subbacterial particles from anaerobic culture of P. deni-
trificans (strain Pd 1222) were prepared according to John
and Whatley [26] as modified [31]. The final preparations of
particles (20 mg/ml) were subjected to brief low-speed
centrifugation to remove contaminating white polymeric
material, most probably poly-h-hydroxybutyrate or other
substrate storage compounds [32].
R. capsulatus strain ATCC 17015 was chemohetero-
trophically grown in the dark in a 1:1 mixture of RCVBN
(minimal medium) and YP (complex medium) supple-
mented with 1.2 mg/l FeSO4 [33]. Two-liter baffled
Erlenmeyer flasks with 400-ml medium in each were
inoculated with 15-ml preculture and placed in an incuba-
tor-shaker at 30 jC and 200 rpm aeration. The bacteriawere harvested by centrifugation after 12–13 h of growth,
washed once in 50 mM Bis–Tris–propane–HCl (pH 7.0),
20 mM KCl, 10 mM MgCl2. The cells were resuspended
in the same buffer and 200 AM protease inhibitor Pefabloc
SC and few flakes of DNAse were added. Membrane
vesicles were prepared by French Press (12000 psi),
followed by low-speed centrifugation (20000 g) for 20
min to remove cell debris. The supernatant was centrifuged
again at 120000 g for 1 h, and pellets were resuspended
by gentle homogenization and washed once (120000 g,
1 h). After the last centrifugation, the pellets were resus-
pended in a minimal volume of the same buffer (ca. 40 mg
protein/ml), distributed in small tubes, frozen in liquid
nitrogen, and stored at  80 jC. All operations were
conducted at 2–4 jC.
NADH oxidation was measured photometrically,
e340 = 6.22, in a standard assay mixture comprised of 0.25
M sucrose, 50 mM Tris/Cl (pH 8.0), 0.2 mM EDTA, 1 mM
MgCl2, and 0.2 Ag/ml of gramicidin D. All the assays were
performed at pH 8.0. This pH was found to be ‘‘optimal’’
for both mammalian [29] and bacterial NADH oxidase
activities although no significant pH dependence was seen
at the pH interval of 6–8.5, except for apparent instability of
the bacterial vesicles (slow decline of the steady state
NADH oxidation when assayed at pH>8). The inclusion
of Mg2 + to the standard reaction mixture deserves special
comment. Relatively rapid NADH oxidation-induced acti-
vation of the mammalian Complex I becomes slow if Mg2 +
is present in the assay mixture [34]. Thus, full enzyme
capacity measured as the initial rate in the presence of Mg2 +
can only be revealed for completely preactivated enzyme
preparations. On the other hand, our inspection of the
literature showed that in vast majority of studies on P.
denitrificans NDH-1, 2–10 mM Mg2 + were present in the
assay mixture. The requirement of bivalent cations for the
stability of NADH-quinone reductase and NADH oxidase in
P. denitrificans membranes has been noted in our previous
work [25]. When NADH oxidase or NADH:Q1 reductase of
P. denitrificans were assayed in the absence of Mg2 +, both
activities rapidly declined. The inactivation was specific for
NADH oxidation (no decline of succinate oxidase was
observed in parallel experiments). This time-dependent
inactivation was not reversed by subsequent addition of
Mg2 +. Both Ca2 + and Mg2 + were almost equally efficient
for the enzyme stabilization (half-maximal concentration
needed to protect the enzymatic activity was 0.2 mM) and
the inactivation rate in the absence of divalent cations was
strongly dependent on the amount of protein in the assay
mixture: the larger amount of protein was added the slower
inactivation was observed (the results are not shown). This
effect of divalent cations on the bacterial Complex I was not
further investigated in the present studies and 1 mM
Mg2 + was always present when bacterial preparations were
assayed.
NADH:ubiquinone oxidoreductase activity was mea-
sured photometrically (e340 = 6.22) in the same assay mix-
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acetate (15 mM) was added to the assay mixtures when
uncoupled activities of P. denitrificans particles were deter-
mined [35].
Succinate-supported Dl˜H+-dependent NAD
+ reduction
(reverse electron transfer) activity was measured photo-
metrically (e340 = 6.22) in the standard assay mixture
containing 5 mM NAD+ and 10 mM potassium succinate
(no uncouplers were present). All the activities of bovine
heart preparations were assayed after complete activation
of Complex I by aerobic oxidation of small amount of
NADH as described [30]. This procedure was not
required for prokaryotic preparations. It has been
reported that P. denitrificans particles show no sign of
slow active/deactive NDH-1 transition [23,25]. We found
that this is also true for R. capsulatus particles (not
shown).
The experimental details are indicated in legends to the
figures and tables. Protein content was determined by biuret
assay [36].
NADH, NAD+, ADP-ribose, potassium succinate,
EDTA, Tris, essentially fatty acid free BSA, Q1, alamethi-
cin, gramicidin D, Triton X-100, and rotenone were from
Sigma. Piericidin Awas a kind gift from Dr. A. Kotlyar (Tel
Aviv University, Israel).Table 1
Catalytic activities of Complex I catalyzed by bovine heart submitochondrial par
Reaction and
kinetic parameters
B. taurus
NADH oxidation
NADH oxidase (Amol/min/mg)b 1.0 (TN= 280 s 1)d
rotenonec 0.01
Km
NADH (AM)e 1.4 (coupled oxidase)
2.2 (uncoupled oxidase)
K i
ADPR (AM)f 25 (coupled oxidase)
25 (uncoupled oxidase)
NADH:Q1 reductase
d (Amol/min/mg)b,g 1.0
rotenonec 0.1
Km
Q1 (AM)h 10
NAD+ reduction
Aerobic succinate-supported
reverse electron transfer (Amol/min/mg)
ADP-ribose (300 AM)
0.2
no inhibition
Km
NAD + (AM)i 7
a The average activities of many preparations are given with the precision of F 2
b Completely uncoupled particles assayed in the presence of gramicidin (B. taurus)
stimulate the activity of R. capsulatus particles.
c Two-micromolar rotenone was added; further increase of the rotenone concentra
d Alamethicin, which permeabilizes the membranes for NADH [39] did not incre
e Determined from the simple linear 1/v versus 1/NADH dependencies seen for a
f Simple competitive (with NADH) inhibition.
g In the presence of 5 mM KCN and 100 AM Q1 as electron acceptor.
h Determined from the simple linear 1/v versus 1/Q1 dependencies in the presenc
i Determined from the linear 1/v versus 1/NAD+ dependencies. Ten-millimolar su
generation.3. Results
3.1. Catalytic activities of Complex I in the membranes of
different species
Bovine submitochondrial particles (SMP) prepared by
the conventional procedure and treated with oligomycin to
block a leakage of protons through Fo component of ATP
synthase catalyze both Dl˜H+-generating NADH oxidation
and Dl˜H+-dependent ubiquinol:NAD
+ oxidoreduction at
comparable rates [14,29]. Subbacterial predominantly in-
side-out oriented P. denitrificans particles [35,37] as pre-
pared are also capable of both reactions, and no artificial
coupling by an Fo-specific inhibitor (venturicidin) was
needed to observe aerobic succinate-supported reverse
electron transfer at the first coupling site [38]. We were
unable to prepare R. capsulatus particles capable of reverse
electron transfer, probably due to a low activity of succi-
nate dehydrogenase in combination with lower respiratory
control ratio in this preparation compared to the other
species, and thus only NADH oxidation activity was
characterized for this preparation. Table 1 summarizes
several parameters of the reactions. As expected, basically
the same properties of the reactions were seen. The data on
absolute content of Complex I in the membranous prepa-ticles and P. denitrificans and R. capsulatus vesicles (pH 8.0, 25 jC)a
P. denitrificans R. capsulatus
0.9 (TN= 800 s 1)d 0.5d
0.01 0.04
2 (coupled oxidase) –
7 (uncoupled oxidase) 6 (uncoupled oxidase)
80 (coupled oxidase) –
80 (uncoupled oxidase)
0.8 0.5
0.1 0.15
20 15
0.1
no inhibition
–
–
270 –
0%.
or gramicidin plus ammonium acetate (P. denitrificans). Uncouplers did not
tion had no effect on the degree of inhibition.
ase the activities of B. taurus and R. capsulatus particles.
ll preparations during the NADH oxidase assay.
e of 200 AM NADH and 5 mM KCN.
ccinate was added as a reductant for endogenous ubiquinone and for Dl˜H+
Table 2
The relative affinities of the ubiquinone-junction site inhibitorsa (pH 8.0, 25 jC)
Inhibitor B. taurus P denitrificans R. capsulatus
NADH oxidase NAD+ reduction NADH oxidase NAD+ reduction NADH oxidase
Rotenone, Ki (AM)b 0.001 0.02 0.5 no inhibition by 1 AM rotenone 0.15
k i
on (M 1 min 1)c 5 107 – 1.1106 – 1.4 106
Triton X-100, Ki (AM) 7 40 50 10 25
a See Materials and methods and footnotes to Table 1 for the details of assay procedures.
b Particles were preincubated with the inhibitor for 5 min before the residual activity was determined.
c Determined from the linear pseudo-first-order semi-log plot of the residual activity versus time after the addition of excess of (over the enzyme concentration)
rotenone to the particles (50 Ag/ml) oxidizing NADH.
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turnover numbers. These were derived from titration of
the enzymatic activities by piericidin according to the
model described in Appendix A. Note should be made
that P. denitrificans vesicles were 65% inside-out as
evident from about 1.6 times stimulation of their NADH
oxidase activity by pore-forming antibiotic alamethicin [39]
(data not shown). This is in accord with the data previously
reported data by Burnell et al. [37]. For the calculations, it
was assumed that two piericidin-specific sites per mole of
Complex I bind the inhibitor equally in inside-out (cata-
lytically active) and inside-in (catalytically inactive)
vesicles and proper corrections were made when Complex
I content was estimated from the titration curves. In ourFig. 1. Titration of NADH oxidase and Dl˜H+-dependent reverse electron transfer
with small aliquots of piericidin (solution in DMSO) for 5 min at 25 jC. The initia
continuous line is the theoretical curve for the residual activities of forward and rev
the parameters: Et = 140 AM; Ki^ = 10 AM; K i_ = 10 AM. It should be noted that tot
membrane lipid phase i.e. mole of enzyme per 1000 cm3 of lipid. For example, if p
is equal to 0.44 mg per milligram of protein [65], the Complex I concentration (Et)
procedure. (B) P. denitrificans vesicles (1 mg/ml) were preincubated with piericidi
reduction (o) were measured. The continuous lines are the theoretical curves acco
Ki
^ = 13 AM; K i_ = 32 AM. (C) R. capsulatus particles (1 mg/ml) were preincubated
(.) were measured. The continuous line is the theoretical curve according the mod
AM; Ki^ = 10 AM; K i_ = 25 AM. One hundred percent activity correspond to 1.2, 1.1
R. capsulatus particles, respectively.experience, variation of NADH oxidase activities of the
bacterial preparations was significantly greater than that for
SMP and the turnover numbers shown in Table 1 should be
considered as provisional. Lower apparent affinities of the
nucleotide binding site for NADH and ADP-ribose were
evident for the bacterial preparations (coupled and
uncoupled) as compared with the mitochondrial enzyme.
The absence of inhibitory effect of ADP-ribose on the
reverse electron transfer reaction previously reported for
the mammalian system was thus confirmed for the P.
denitrificans membranes in agreement with recent data of
Kotlyar and Borovok [38]. The rotenone-insensitive frac-
tion of the NADH:Q1 reductase activity was substantially
larger in R. capsulatus membranes.with piericidin. (A) Submitochondrial particles (0.5 mg/ml) were incubated
l rates of NADH oxidation (.) or NAD+ reduction (o) were measured. The
erse electron transfer according to the model described by Eqs. (7)– (9) with
al concentration of the enzyme (Et) here refers to molar concentration in the
iericidin titer is equal to 0.12 nmol per milligram of protein and lipid content
in lipid phase would be 140 AM. See Appendix A for the details of the fitting
n as described in (A) and the initial rates of NADH oxidation (.) or NAD+
rding the model described by Eqs. (7)– (9) with the parameters: Et = 64 AM;
with piericidin as described in (A) and the initial rates of NADH oxidation
el described by Eqs. (7)– (9) with the parameters (defined as above): Et = 50
, and 0.5 Amol/min/mg of protein for submitochondrial, P. denitrificans, and
Fig. 2. P. denitrificans NADH oxidase titrations with piericidin at different
enzyme concentrations. Particles were preincubated for 5 min (o, .) or
10 min (n) at 25 jC with piericidin, and the residual NADH oxidase
activity was measured. The protein content during preincubation was: (n)
0.1 mg/ml; (o) 1 mg/ml; and (.) 10 mg/ml. Special care was taken to
assure that the equilibration in the preincubation mixtures was complete,
i.e. increase of preincubation time at any protein and piericidin
concentrations did not change the final level of the residual activity.
The continuous line is the theoretical curve for the two-site model (see
Appendix A) with the parameters: Et = 62 AM, K i^ = 13 AM, K i_ = 32 AM.
See legend to Fig. 1 for definitions. One hundred percent activity correspond
to 0.9 Amol/min/mg of protein.
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inhibitors
Rotenone specifically inhibits the bulk ubiquinone re-
duction by Complex I [40,41]. It has been documented that
rotenone blocks the enzyme activity either as ‘‘irreversible’’
(straight line titration) or ‘‘reversible’’ (curvilinear titration)
inhibitor depending on the concentration of Complex I
under the assay conditions (E>Ki, or E <Ki, respectively)
[41] (see Appendix A for more details). The striking finding
reported earlier for mammalian submitochondrial particles is
that uncoupled or coupled NADH oxidation activities are
significantly more sensitive to rotenone than the Dl˜H+-
dependent ubiquinol:NAD+ reductase reaction (reverse elec-
tron transfer) whereas the apparent affinity of rotenone to its
specific binding site (s) does not depend on Dl˜H+ [41].
Qualitatively, the same pattern was demonstrated for another
Complex I-specific inhibitor, Triton X-100 [42]. Consider-
ably lower inhibitory efficiency of rotenone (more than two
order of magnitude) and Triton X-100 were found for
prokaryotic NDH-1 (Table 2). In fact, no inhibition of the
reverse electron transfer by 1 AM rotenone was seen for P.
denitrificans preparations. This result is somewhat expected:
if the difference in inhibitory efficiency of rotenone for the
forward and reverse reactions is approximately the same (20
times) for the mammalian and bacterial enzymes, the
apparent Ki in the latter case would be as high as 8 AM,
which is considerably higher than that used in our experi-
ments because of the solubility limit for the inhibitor [41].
Unexpectedly, although the difference in sensitivities of the
forward and reverse reactions catalyzed by P. denitrificans
particles to Triton X-100 was evident, its directional ‘‘spec-
ificity’’ was opposite to that found for the mammalian
enzyme. At present, we are unable to offer any explanation
for this finding. Note should be made that although inhib-
itory effect of Triton X-100 on the mammalian Complex I
has been well characterized kinetically [42], the mechanism
of its action remains unknown.
3.3. Titration of the Complex I activity with piericidin
Fig. 1A shows the inhibition of the forward (NADH
oxidase) and the reverse (Dl˜H+-dependent ubiquinol:NAD
+
reductase) electron transfer activities of submitochondrial
particles by piericidin. The titration patterns for either
forward or reverse activity were the same, and full inhibi-
tion, as estimated by extrapolation of the straight lines to
abscissa, was reached at 0.12 nmol of piericidin per milli-
gram of protein. This value is in close agreement with the
previously determined rotenone titer for the NADH oxidase
reaction of the same preparation (0.14 nmol per milligram of
protein [41]). The titration pattern, for both forward and
reverse electron transfer (almost straight lines, Fig. 1A),
would be expected if a single common tight binding site for
piericidin is present. The same titration pattern would be
observed if the two separate noninteracting sites exist with
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observed for the bacterial membranes. When the piericidin
sensitivities of the forward, NADH oxidase reaction of P.
denitrificans and R. capsulatus particles were investigated
the titrations were curvilinear (Fig. 1B,C, closed circles).
This would be expected if piericidin has significantly lower
affinity to the prokaryotic enzymes and reversible equili-
bration of the enzyme and inhibitor occurred under the
conditions: E <Ki (see Appendix A). However, this was
demonstrated not to be the case when bacterial membrane
vesicles were equilibrated with piericidin at two order of
magnitude range of protein content exactly the same titra-
tion curves were obtained for ‘‘concentrated’’ and ‘‘diluted’’
systems (Fig. 2), thus suggesting that the conditions E>Ki
hold for any dilution employed in the titration experiments.
It was thus evident that the inhibitory efficiency of piericidin
in the NADH oxidase assay depends on the stoichiometric
enzyme/inhibitor ratio and is independent of the absolute
concentrations of enzyme and inhibitor.
Although the inhibitory effect of piericidin could not be
abolished by a dilution of the enzyme–inhibitor complex,
the NADH oxidase activity of P. denitrificans particles was
rapidly restored in the presence of BSA (Fig. 3). Interest-
ingly, the rate of reactivation was independent of BSA
concentration providing that amount of the latter was
Fig. 3. Reactivation of piericidin-inhibited NADH oxidase of P. denitri-
ficans by bovine serum albumin (BSA). Particles (1 mg/ml) were pre-
incubated without (curve 1) or with piericidin (0.3 nmol/mg of protein)
(curve 2) for 5 min at 25 jC and their NADH oxidase was measured by the
addition of small aliquots (dilution factor of 40) as indicated by arrow to the
standard reaction mixture. Curves 3 and 4, 1 and 10 mg of BSA per milliliter
was added to the assays, respectively.
V.G. Grivennikova et al. / Biochimica et Biophysica Acta 1607 (2003) 79–9084sufficient to restore about 80–90% of the original activity.
Significantly smaller fraction, less than 30% of the original
activity, could be restored by BSA if submitochondrial
particles were preincubated with piericidin and their NADH
oxidase activity was further assayed as shown in Fig. 3 (the
results are nor shown).
When the forward and reverse electron transfer activities
of P. denitrificans particles were titrated by piericidin, a
significantly lower sensitivity of the latter reaction was
evident (Fig. 1B). The titration of R. capsulatus NADH
oxidase inhibition by piericidin was qualitatively the same
as that for P. denitrificans membranes (Fig. 1C). The
sensitivity of the reverse reaction to either piericidin or
rotenone could not be examined in R. capsulatus, since we
were unable to obtain vesicles capable of measurable Dl˜H+-
dependent quinol:NAD+ reductase activity.4. Discussion
Prokaryotic proton-translocating NDH-1 type enzymes
(P. denitrificans, R. capsulatus, E. coli) are much simpler
compare to their eukaryotic counterparts (B. taurus, N.
crassa [43], Y. lipolytica [44]) in terms of their polypep-
tide composition, although the EPR and thermodynamic
properties of their redox components are almost identical
to those of bovine heart Complex I [22,45]. The efficiency
of energy transduction at NADH-ubiquinone region of therespiratory chain is also the same for bovine heart [46]
and P. denitrificans membranes [47]. It could be expected
that the lack of about 30 extra subunits in prokaryotic
NDH-1 would affect their catalytic properties. The data
reported here (Table 1) show that this is not the case and
only slight differences in the kinetic parameters of the
overall NADH oxidation were found. Among those is a
significantly lower affinity of the nucleotide-binding sites
for NADH and NAD+. The absence of inhibitory effect of
ADP-ribose on the reverse electron transfer has been
originally reported for bovine heart submitochondrial par-
ticles [48]. This phenomenon have been recently con-
firmed by Kotlyar and Borovok [38] for P. denitrificans
membranes. Our data (see Table 1) agree with their
results, but not with their interpretation. They have con-
cluded that inability of ADP-ribose to inhibit reverse
electron transfer is due to the energy-dependent change
of the nucleotide-binding site affinity [38]. Such interpre-
tation fails to explain the almost same Km values for
coupled and uncoupled NADH oxidation and equal Ki’s
for ADP-ribose induced inhibition of NADH oxidase
activity catalyzed by coupled or uncoupled particles [11]
(Table 1). We interpret the unidirectional effect of ADP-
ribose on NADH oxidation/reduction such that two differ-
ent nucleotide-specific sites are operating in the forward
and reverse reactions. This explanation accounts for the
absence of an inhibitory effect of NAD+ during NADH
oxidation, and for relatively high affinity for NAD+ during
the reverse reaction (Km values of 7.2 and 270 AM for
bovine heart and P. denitrificans, respectively). Which
particular subunit of the bacterial enzymes binds NAD+
(harbors the second site) remains to be determined. Our
results provide evidence that the NAD+ binding subunit
does not belong to the ‘‘extra’’ 32 subunits of the
mammalian enzyme. No other than the 50 kDa (NUO F)
subunit is found in the sequences of the bacterial Complex
I to show typical nucleotide binding motif. Thus, the
proposal on the presence of two separate binding sites
for NADH and NAD+, which has been supported by our
previous [48,49] and present data (Table 1), seems to
contradict the structural information. However, it is perti-
nent to note that five polypeptides have been reported to
be labeled by 32P-adenine dinucleotides and ADP in the
mammalian Complex I [50], while only two nucleotide-
binding sites has been identified by the consensus motifs
(51 and 39 kDa subunits of the bovine heart Complex I
[51]). The presence of numerous nonclassical folding
patterns in proteins that bind NAD(P)+ [52] should also
be kept in mind.
The prokaryotic enzymes show significantly lower sen-
sitivity to the ‘‘reversible’’ quinone-junction site inhibitors
as compared with the mammalian Complex I (Table 2).
Also, qualitative difference in the titration of the forward
and reverse reactions by piericidin was evident when the
mammalian and P. denitrificans preparation were compared.
The sensitivity of either reaction to piericidin in SMP was
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the inhibitor than the forward reaction (Fig. 1A,B) in the
bacterial system. According to the model described in
Appendix A, two specific noninteracting piericidin-sensitive
sites with equal affinities operate in the mammalian system
whereas the affinities of these sites in P. denitrificans to
piericidin considerably differ. Another dissimilarity between
the preparations is the substantially higher rotenone-insen-
sitive fraction of the NADH:Q1 reductase reaction catalyzed
by R. capsulatus membranes. It has been shown that the
rotenone (and piericidin)-insensitive fraction of the
NADH:Q1 reductase reaction in submitochondrial particles
is completely coupled, i.e. the inhibited enzyme translocates
four proton per two electrons transferred from NADH to
external quinone [46,53]. It would be of great interest to
utilize this relatively high rotenone-insensitive reaction for
measuring the proton/electron stoichiometry in R. capsula-
tus membranes.
Perhaps the most striking observation emerging from
this comparative study is the unexpected pattern of pier-
icidin titration as depicted in Figs. 1 and 2. Three points
are worth to emphasize. (i) In submitochondrial particles,
the titration curves for the forward and reverse reactions
are the same and they behave as expected for very tight
(almost irreversible) site-specific inhibition, i.e. straight
line-type titration. (ii) For prokaryotic preparations (P.
denitrificans and R. capsulatus), the titration lines are
clearly curvilinear, as expected for relatively low-affinity
inhibition. However, the I50 values do not depend on
dilution of the enzyme–inhibitor equilibrating medium
(Fig. 2) and this latter observation evidently contradicts
the assumption on low-affinity inhibition. (iii) The sensi-
tivities of forward and reverse electron transfer in P.
denitrificans particles to piericidin are different, an obser-
vation that corroborates our previous finding of a similar
pattern of rotenone inhibition in submitochondrial particles
[41]. In contrast to other authors’ claims [54], it has been
shown that the affinity of Complex I to rotenone does not
depend on the energization of the coupling membrane.
Thus, two binding sites for rotenone, which specifically
inhibits separate electron transfer pathways for NADH:
quinone and quinol:NAD+ oxidoreduction, have been pro-
posed [41].
The sensitivities of different reactions and enzyme redox
components in the membrane-bound mammalian Complex I
have been extensively investigated in a number of earlier
studies [55–60] and more recently for particles derived
from wild-type and mutant R. capsulatus [27,28]. We
believe that some contradictions in the data on piericidin
titrations reported earlier were most likely due to an unrec-
ognized heterogeneity of the mammalian enzyme prepara-
tions. Most, if not all, preparations of submitochondrial
particles contain a mixture of active and deactivated Com-
plex I (reviewed in Refs. [14,61]) with different affinities of
the two forms to quinone-junction site inhibitors [41]. The
experiments reported here were carried out with eithercompletely activated preparations or with prokaryotic
enzymes, which are not subjected to active/deactive Com-
plex I transition [23,25].
It seemed unlikely that a qualitative difference in the
piericidin inhibition mechanism exists for the mammalian
and prokaryotic enzymes, except for lower binding site(s)
affinity to the inhibitor in the latter preparations. Thus, a
general model, explaining the findings (i– iii) listed above,
is required. Here we propose such a model, based on the
following assumptions. (a) Two binding sites for piericidin
and other inhibitors of the terminal quinone oxidoreduction
exist in Complex I and the inhibitors bound at these two
noninteracting sites prevent either forward or reverse reac-
tion. (b) Piericidin as any extremely hydrophobic compound
quantitatively binds to the bulk lipid phase of the mem-
brane. This assumption is supported by the data of Horgan
et al. [57], who have shown quantitative binding as much as
0.3 nmol per milligram of protein of 14C-piericidin by
submitochondrial particles. This amount is about four times
higher than that required for complete inhibition of Com-
plex I activities (see Fig. 1A). (c) The interaction of
piericidin with the enzyme occurs within the lipid phase
or at the membrane–water interphase and the specific
binding sites are accessible only for the inhibitor dissolved
in the lipid. (d) All species participating in the interactions
within the lipid phase are in rapid equilibrium. This is
equivalent to an assumption that no ‘‘tight’’ slowly dissoci-
ating enzyme–inhibitor complexes exist. Our model is thus
somewhat similar to that proposed by Bechmann et al. [62]
as an explanation for the nonlinear inhibition curves
obtained for antimycin A titrations of dimeric ubiquinol:cy-
tochrome c oxidoreductase. The detailed step-by-step ap-
proximation to the model and quantitative parameters used
to fit the actual data to the theoretical curves are given in
Appendix A. As shown in Fig. 1, all the experimental data
on piericidin titration satisfy two-site model as described in
Appendix A.
We showed that BSA rapidly restores piericidin-
inhibited activity of P. denitrificans particles, whereas
the inhibition was not reversed by dilution (Figs. 2 and
3). The most plausible explanation for these apparently
contradictory observations is that BSA binds to the
particles and direct transfer of the inhibitor from the
lipid phase to the BSA hydrophobic pocket occurs. Such
mechanism for the serum albumin-mediated cellular up-
take of long-chain fatty acids has been demonstrated [63].
Only very small recovery of the piericidin-inhibited
NADH oxidase after several washings with BSA at 0
jC (3.9%) has been found in earlier studies on rotenone
and piericidin sensitivities of the mammalian Complex I
[56–58]. We found significantly higher recovery for SMP
(f 30%) (see Results) and for P. denitrificans vesicles
(Fig. 3). Apparent discrepancy between our results and
those reported by Singer’s group most probably lies in
different experimental conditions employed: 0 jC, 25
mM phosphate, pH 7.4 [56–58] and 25 jC, 50 mM
V.G. Grivennikova et al. / Biochimica et Biophysica Acta 1607 (2003) 79–9086Tris/Cl, pH 8.0 (present studies). Should our proposal
on direct transfer of the inhibitor to BSA be correct, the
inhibition reversal is expected to depend on ionic com-
position of the medium.Acknowledgements
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Understanding the mechanism of inhibition in terms of
characteristics of binding sites and dissociation constants for
specific inhibitors have proved to be an important strategy
in bioenergetic research. Although the detailed kinetic
analysis of tight-binding inhibitors have been extensively
discussed in a number of reviews (Ref. [64] and references
cited in our previous publication [41]), we felt that brief
quantitative account of different plausible models describing
enzyme–inhibitor interaction is relevant to the studies on
Complex I directed inhibitors and it may also be helpful for
the analysis of other mitochondria-specific inhibitors
(uncouplers, FoF1-ATPase inhibitors, multiple respiratory
chain-directed inhibitors).
A.1. Single site-directed high-affinity inhibition
If the enzyme reversibly binds an inhibitor at a single
binding site:
E þ I XKi E  I ð1Þ
the dissociation constant then:
Ki ¼ ðEt  E  IÞðIt  E  IÞ
E  I ð2Þ
where Et and It are the total concentration of the enzyme and
inhibitor (free and bound) and EI is the concentration of the
enzyme–inhibitor complex at equilibrium. From Eq. (2), thetotal inhibitor concentration required to halve free enzyme
capable of enzymatic activity (I t
0.5) is:
I 0:5t ¼ 0:5Et þ Ki ð3Þ
If the dissociation rate constant is very small compared to
the enzyme turnover as it is the case for a number of tightly
bound inhibitors (rotenone, piericidin, antimycin, oligomy-
cin), the residual activity, which is proportional to free
enzyme concentration, can be easily determined indepen-
dent of whether the substrates compete with inhibitor or not
(no shift of equilibrium (1) occurs during the assay). It
follows from Eq. (2) that the residual activity as a function
of added inhibitor concentration (It) is reciprocal of a
positive root of square equation with Et, It, and Ki as the
parameters. The titration curves E (residual activity) versus
It appear qualitatively different at different Ki at constant Et
as shown in Fig. 4A. At KibEt, the titration appears as a
straight line up to high degree of inhibition (curve 1) and
extrapolation of this line intercept abscissa at ItfEt. An
obvious extreme case (It =Et) is when Ki = 0 (irreversible
site-specific inhibition). When Ki>Et, the titration appears as
a descending curve, and as follows from Eq. (3), the half-
maximal inhibition is reached at It =Ki (Fig. 4A, curve 4).
At intermediate cases, when KifEt, the I t
0.5 is equal to
neither 0.5 Et nor Ki, as depicted in Eq. (3), and are shown
in Fig. 4A, curves 2 and 3). An important consequence of
this simple consideration is that the appearance (shape) of
the titration depends on a dilution of the equilibration
medium as shown in Fig. 4B. The ‘‘straight line’’ titration
seen at high enzyme concentration becomes curvilinear
when the enzyme concentration becomes comparable with
Ki. Indeed, a different pattern of the bovine heart Complex I
titration by rotenone was observed for concentrated and
diluted samples [41].
A.2. Two-site-directed, high-affinity inhibition
Assuming that the enzyme has two noninteracting bind-
ing sites with different affinities for an inhibitor:
ð4Þ
Fig. 5. The titration curves simulated according to the model described in
Eqs. (7)– (9) (two tight-binding site model). Parameters used for simulation:
Et = 20 AM, Ki^ = 0.1 AM, K i_ = 1 AM (curve 1, forward reaction; curve 2,
reverse reaction). Line 3 and 4 (coincided), forward and reverse reaction if
Ki
^ =K i
_ = 0.1 AM. The dotted line simulated according to the model
described in Eq. (2) (single tight-binding site model). Parameters used for
simulation: Et = 20 AM, K i^ = 0.1 AM. See Legend to Fig. 1 for definitions.
Fig. 4. Simulated curves for high-affinity inhibition according to Eq. (2) with a depletion of free inhibitor due to its binding to the enzyme. (A) Parameters for
Eq. (2) were: Et = 20 AM; Ki = 1, 10, 50, and 200 AM for curves 1, 2, 3, and 4, respectively. (B) Titrations curves at constant Ki (1 AM) and different enzyme
concentrations: 50, 20, 10, 5, and 1 AM for curves 1, 2, 3, 4, and 5, respectively. See legend to Fig. 1 for definitions.
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m_, respectively) can be measured independently, then at
equilibrium total enzyme concentration:
Et ¼ _E^ þ _E^I þ I_E^ þ I_E^ I ð5Þ
It ¼ I þ _E^ I þ I_E^ þ 2ðI_E^IÞ ð6Þ
If the activity m^ is catalyzed by _E^ and I_E^ at equal
efficiencies and the activity m_ is catalyzed by _E^ and
_E^I at equal efficiencies, then the normalized catalytic
activities at any concentration of the inhibitor are:
v^i =v
^
0 ¼
K ^i
K^i þ I
ð7Þ
and
v_i =v
_
0 ¼
K_i
K _i þ I
ð8Þ
The free inhibitor concentration as appears in denomi-
nators of Eqs. (7) and (8) is a positive root of cubic
equation:
I3 þ ðK_i þ K^i þ 2Et  ItÞI2 þ ½K_i  K^i þ ðK_i þ K^i Þ  Et
 ðK_i þ K^i Þ  It  K_i  K^i  It ¼ 0 ð9ÞFig. 5 shows the dependence of the normalized m^ and m_
activities on concentration of It as solved using Eqs. (7)–
(9) for conditions: Et>Ki
_, Et>K i
^, and different Ki’s. The
Fig. 6. The titration curves simulated according to the model described in
Eqs. (7)– (9) and assuming complete binding of the hydrophobic inhibitor
by the lipid phase and two enzyme-binding sites with weak interaction
within the phospholipid bilayer. The dotted and dashed curves correspond
to the forward and reverse electron transfer inhibition, respectively, if the
parameters for Eqs. (7)– (9) are: Et = 64 AM; K i^ = 6 AM; K i_ = 16 AM.
Curves (.) and (o), the forward and reverse electron transfer, respectively,
with the parameters for Eqs. (7)– (9) were: Et = 64 AM; K i^ = 13 AM;
K i
_ = 32 AM. The latter parameters were used to fit P. denitrificans titration
data as shown in Fig. 1B. Note that slight variation of K i
^ and K i
_ at
constant Et causes significant change in the titration pattern. See legend to
Fig. 1 for definitions.
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significantly lower inhibitor concentrations as compared
with the single-site titration (shown by dotted line). The
titration of the activity catalyzed by the lower-affinity site
(m_) shows significant ‘‘lag’’ (the larger the difference
between K i
^ and K i
_ the more significant ‘‘lag’’ appears).
The titration curves for either activity become indistinguish-
able when K i
_ =K i
^ and extrapolated line intercept abscissa
at two inhibitor equivalent per mole of the enzyme.
A.3. Titration with a very hydrophobic inhibitor
It is evident that both a single-site directed high-affinity
inhibition and two-site high-affinity inhibition models fail
to explain the actual piericidin titration curves for forward
and reverse electron transfer as observed for prokaryotic
Complex I (Fig. 1B,C). The first model is (single-site tight
inhibition) inadequate because it fails to explain the
significant curvilinearity of the titration at any concentra-
tion of the enzyme preparation (Fig. 2). The second (two-
sites) model fails to explain the difference between titration
of forward and reverse electron transfer without a notable
‘‘lag’’, which is expected, as shown in Fig. 5. We felt that
the two-site model could explain the actual titration data if
the implicit assumption for ‘‘tight’’ binding would not be
fulfilled. This assumption seems unrealistic because a very
low (close to stoichiometric) amount of piericidin is
required for almost complete block of NADH oxidation.
However, the strong hydrophobicity of the inhibitor may
be a key factor for the apparent inconsistencies. If all the
inhibitor added is bound to the lipid phase where the
binding sites are located, the dilution factor does not hold,
and intrinsic binding constants within the hydrophobic
environment may not be as high as it appears from
superficial consideration. The starting parameter (Et) to
fit the experimental data to Eq. (9) in case of a relatively
weak enzyme–piericidin interaction can be estimated as
follows. If 0.12 nmol per milligram of protein is taken
from the straight-line titration by piericidin, the actual
concentration of the enzyme in lipid phase is equal to
1.4 10 4 M, assuming the lipid content of 0.44 mg per
milligram of protein [65] and the stoichiometry of 2
piericidin per mole of Complex I. The submitochondrial
particles quantitatively (i.e. irreversibly) bind much larger
amount of piericidin than that required for full inhibition of
Complex I [57]. The content of lipid phase in the bacterial
membranes is taken as 0.48 mg per milligram of protein
[32]. Thus, the concentration of piericidin in the lipid
phase during the course of titrations, as shown in Fig. 1,
was changed in the range 0–3.6 10 4 M. The quantita-
tive solution for the titration by piericidin as described by
the two-site model (Eqs. (7)–(9)), under the assumption of
‘‘weak’’ interaction within the lipid phase, is shown in
Fig. 6. After the qualitative resemblance of the theoretical
curves for the titrations have been reached (dotted and
dashed lines), further variations of the parameters K i
^ andK i
_ were made to fit the experimental points quantitatively.
Although we do not give here the detailed mathematical
analysis of the model as described, it should be emphasized
that at any given constant Et, the theoretical line shape is
quite sensitive to small K i
^ and K i
_ variations (see Fig. 6).References
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